13F Data
13F filer · CIK 1515070

Tetragon Partners GP Ltd

GRAND CAYMAN, E9 · filing since Q2 2013 · last filing Aug 13, 2026
Reported value
$635.1M
+$119.9M vs prior
Positions
39
New / sold out
10 / 7
Added / reduced
16 / 5
Turnover
6.4%
buys $132.0M · sells $37.1M
Top-10 weight
74.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedUIPATH INC+5,742,372+22.8%+$62.4M
NewALKAMI TECHNOLOGY INC+600,284–+$10.9M
AddedRELAY THERAPEUTICS INC+388,768+214.1%+$7.3M
NewCELCUITY INC+64,110–+$6.7M
AddedIONIS PHARMACEUTICALS INC+55,409+132.7%+$4.4M
AddedDEFINIUM THERAPEUTICS INC+86,996+43.5%+$4.1M
NewULTRAGENYX PHARMACEUTICAL INCALL+100,000–+$3.3M
NewSILENCE THERAPEUTICS PLCCALL+300,000–+$3.3M
AddedMBX BIOSCIENCES INC+58,063+39.9%+$3.2M
AddedHARMONY BIOSCIENCES HLDGS IN+81,696+68.5%+$3.0M
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedWARNER BROS DISCOVERY INC-673,725-72.9%$-18.0M
Sold outPRAXIS PRECISION MEDICINES I-15,952-100.0%$-5.1M
Sold outSOLENO THERAPEUTICS INC-102,125-100.0%$-3.4M
Sold outAXSOME THERAPEUTICS INC.-20,059-100.0%$-3.4M
Sold outMAPLIGHT THERAPEUTICS INC-112,115-100.0%$-2.3M
Sold outAARDVARK THERAPEUTICS INC-316,621-100.0%$-1.2M
ReducedNEKTAR THERAPEUTICS-16,041-15.6%$-1.1M
Sold outULTRAGENYX PHARMACEUTICAL IN-39,473-100.0%$-827.0K
ReducedCELLDEX THERAPEUTICS INC NEW-21,875-7.0%$-814.0K
ReducedAMYLYX PHARMACEUTICALS INC-19,951-6.3%$-358.3K
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $140.9MQ3 2013: $99.0MQ4 2013: $110.6MQ1 2014: $181.3MQ2 2014: $355.4MQ3 2014: $292.2MQ4 2014: $253.4MQ1 2015: $322.1MQ2 2015: $269.9MQ3 2015: $207.7MQ4 2015: $9.2MQ1 2016: $315.4MQ2 2016: $439.1MQ3 2016: $528.3MQ4 2016: $503.5MQ1 2017: $533.1MQ2 2017: $672.2MQ3 2017: $616.5MQ4 2017: $659.1MQ1 2018: $646.1MQ2 2018: $731.0MQ3 2018: $835.7MQ4 2018: $633.9MQ1 2019: $804.3MQ2 2019: $688.9MQ3 2019: $560.8MQ4 2019: $672.9MQ1 2020: $577.9MQ2 2020: $751.0MQ3 2020: $987.6MQ4 2020: $1.5BQ1 2021: $1.4BQ2 2021: $1.8BQ3 2021: $1.6BQ4 2021: $1.7BQ1 2022: $2.2BQ2 2022: $1.5BQ3 2022: $829.7MQ4 2022: $699.0MQ1 2023: $747.5MQ2 2023: $740.6MQ3 2023: $548.3MQ4 2023: $415.3MQ1 2024: $441.5MQ2 2024: $400.9MQ3 2024: $354.5MQ4 2024: $391.4MQ1 2025: $438.2MQ2 2025: $620.8MQ3 2025: $747.6MQ4 2025: $474.3MQ1 2026: $515.1MQ2 2026: $635.1M
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1UIPATH INCCL A30,950,000$336.4M52.98%
2KOLIBRI GLOBAL ENERGY INCCOM NEW6,834,504$33.8M5.33%
3AUTOLUS THERAPEUTICS LTDSPON ADS9,500,000$15.2M2.39%
4LYFT INCCL A COM1,000,000$14.6M2.30%
5DEFINIUM THERAPEUTICS INCCOM SHS286,990$13.5M2.13%
6WORKIVA INCCOM CL A250,000$12.1M1.91%
7SPRINKLR INCCL A2,200,000$11.4M1.79%
8MBX BIOSCIENCES INCCOM203,543$11.2M1.77%
9ALKAMI TECHNOLOGY INCCOM600,284$10.9M1.71%
10CELLDEX THERAPEUTICS INC NEWCOM NEW290,441$10.8M1.70%
29 more rows. Subscribe for $29/month to see every row, download the data and use the API.